Annual FCF
-$9.43 M
-$8.44 M-849.55%
31 December 2023
Summary:
Ocean Biomedical annual free cash flow is currently -$9.43 million, with the most recent change of -$8.44 million (-849.55%) on 31 December 2023. During the last 3 years, it has fallen by -$8.38 million (-795.44%).OCEA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$290.00 K
+$195.00 K+40.21%
30 June 2024
Summary:
Ocean Biomedical quarterly free cash flow is currently -$290.00 thousand, with the most recent change of +$195.00 thousand (+40.21%) on 30 June 2024. Over the past year, it has increased by +$576.00 thousand (+66.51%). OCEA quarterly FCF is now -236.34% below its all-time high of $212.70 thousand, reached on 31 December 2022.OCEA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$2.77 M
+$4.49 M+61.85%
30 June 2024
Summary:
Ocean Biomedical TTM free cash flow is currently -$2.77 million, with the most recent change of +$4.49 million (+61.85%) on 30 June 2024. Over the past year, it has increased by +$4.01 million (+59.12%). OCEA TTM FCF is now -1723.03% below its all-time high of -$152.00 thousand, reached on 30 June 2022.OCEA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OCEA Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +66.5% | +59.1% |
3 y3 years | -795.4% | - | - |
5 y5 years | -100.0% | - | - |
OCEA Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -849.5% | at low | -236.3% | +93.9% | -1723.0% | +61.9% |
5 y | 5 years | at low | -236.3% | +93.9% | -1723.0% | +61.9% | |
alltime | all time | <-9999.0% | at low | -236.3% | +93.9% | -1723.0% | +61.9% |
Ocean Biomedical Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2024 | - | -$290.00 K(-40.2%) | -$2.77 M(-61.8%) |
Mar 2024 | - | -$485.00 K(-44.0%) | -$7.26 M(+7.2%) |
Dec 2023 | -$9.43 M(+849.5%) | -$866.00 K(-23.4%) | -$6.78 M(+18.9%) |
Sept 2023 | - | -$1.13 M(-76.4%) | -$5.70 M(+13.7%) |
June 2023 | - | -$4.78 M(-2348.2%) | -$5.01 M(+1214.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2022 | -$993.00 K(-5.7%) | $212.70 K(-148.1%) | -$381.30 K(-35.8%) |
Sept 2022 | - | -$442.00 K(+190.8%) | -$594.00 K(+290.8%) |
June 2022 | - | -$152.00 K | -$152.00 K |
Dec 2021 | -$1.05 M(+1545.3%) | - | - |
Dec 2020 | -$64.00 K(<-9900.0%) | - | - |
Dec 2019 | $0.00 | - | - |
FAQ
- What is Ocean Biomedical annual free cash flow?
- What is the all time high annual FCF for Ocean Biomedical?
- What is Ocean Biomedical quarterly free cash flow?
- What is the all time high quarterly FCF for Ocean Biomedical?
- What is Ocean Biomedical quarterly FCF year-on-year change?
- What is Ocean Biomedical TTM free cash flow?
- What is the all time high TTM FCF for Ocean Biomedical?
- What is Ocean Biomedical TTM FCF year-on-year change?
What is Ocean Biomedical annual free cash flow?
The current annual FCF of OCEA is -$9.43 M
What is the all time high annual FCF for Ocean Biomedical?
Ocean Biomedical all-time high annual free cash flow is $0.00
What is Ocean Biomedical quarterly free cash flow?
The current quarterly FCF of OCEA is -$290.00 K
What is the all time high quarterly FCF for Ocean Biomedical?
Ocean Biomedical all-time high quarterly free cash flow is $212.70 K
What is Ocean Biomedical quarterly FCF year-on-year change?
Over the past year, OCEA quarterly free cash flow has changed by +$576.00 K (+66.51%)
What is Ocean Biomedical TTM free cash flow?
The current TTM FCF of OCEA is -$2.77 M
What is the all time high TTM FCF for Ocean Biomedical?
Ocean Biomedical all-time high TTM free cash flow is -$152.00 K
What is Ocean Biomedical TTM FCF year-on-year change?
Over the past year, OCEA TTM free cash flow has changed by +$4.01 M (+59.12%)